CIBC Private Wealth Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.2M | Buy |
|
|||||
|
2025
Q1 | $46.1M | Buy |
|
|||||
|
2024
Q4 | $48.9M | Sell |
|
|||||
|
2024
Q3 | $57.3M | Buy |
|
|||||
|
2024
Q2 | $52.7M | Buy |
|
|||||
|
2024
Q1 | $26.7M | Buy |
|
|||||
|
2023
Q4 | $33.2M | Sell |
|
|||||
|
2023
Q3 | $30.8M | Sell |
|
|||||
|
2023
Q2 | $33.1M | Buy |
|
|||||
|
2023
Q1 | $24.2M | Sell |
|
|||||
|
2022
Q4 | $28.6M | Buy |
|
|||||
|
2022
Q3 | $23.9M | Buy |
|
|||||
|
2022
Q2 | $17M | Sell |
|
|||||
|
2022
Q1 | $19.6M | Buy |
|
|||||
|
2021
Q4 | $20.1M | Sell |
|
|||||
|
2021
Q3 | $22.5M | Buy |
|
|||||
|
2021
Q2 | $20.1M | Sell |
|
|||||
|
2021
Q1 | $17.8M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1K | Sell |
|
|||||
|
2017
Q4 | $960K | Buy |
|